Trials / Completed
CompletedNCT00828724
Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State
An Open Label, Single Dose, Cross-over Study to Assess the Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the PK properties in fed and fasted men and women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lorcaserin 10mg |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2009-01-26
- Last updated
- 2019-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00828724. Inclusion in this directory is not an endorsement.